Cargando…
The social value of a QALY: raising the bar or barring the raise?
BACKGROUND: Since the inception of the National Institute for Health and Clinical Excellence (NICE) in England, there have been questions about the empirical basis for the cost-per-QALY threshold used by NICE and whether QALYs gained by different beneficiaries of health care should be weighted equal...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023672/ https://www.ncbi.nlm.nih.gov/pubmed/21223540 http://dx.doi.org/10.1186/1472-6963-11-8 |
_version_ | 1782196674863562752 |
---|---|
author | Donaldson, Cam Baker, Rachel Mason, Helen Jones-Lee, Michael Lancsar, Emily Wildman, John Bateman, Ian Loomes, Graham Robinson, Angela Sugden, Robert Prades, Jose Luis Pinto Ryan, Mandy Shackley, Phil Smith, Richard |
author_facet | Donaldson, Cam Baker, Rachel Mason, Helen Jones-Lee, Michael Lancsar, Emily Wildman, John Bateman, Ian Loomes, Graham Robinson, Angela Sugden, Robert Prades, Jose Luis Pinto Ryan, Mandy Shackley, Phil Smith, Richard |
author_sort | Donaldson, Cam |
collection | PubMed |
description | BACKGROUND: Since the inception of the National Institute for Health and Clinical Excellence (NICE) in England, there have been questions about the empirical basis for the cost-per-QALY threshold used by NICE and whether QALYs gained by different beneficiaries of health care should be weighted equally. The Social Value of a QALY (SVQ) project, reported in this paper, was commissioned to address these two questions. The results of SVQ were released during a time of considerable debate about the NICE threshold, and authors with differing perspectives have drawn on the SVQ results to support their cases. As these discussions continue, and given the selective use of results by those involved, it is important, therefore, not only to present a summary overview of SVQ, but also for those who conducted the research to contribute to the debate as to its implications for NICE. DISCUSSION: The issue of the threshold was addressed in two ways: first, by combining, via a set of models, the current UK Value of a Prevented Fatality (used in transport policy) with data on fatality age, life expectancy and age-related quality of life; and, second, via a survey designed to test the feasibility of combining respondents' answers to willingness to pay and health state utility questions to arrive at values of a QALY. Modelling resulted in values of £10,000-£70,000 per QALY. Via survey research, most methods of aggregating the data resulted in values of a QALY of £18,000-£40,000, although others resulted in implausibly high values. An additional survey, addressing the issue of weighting QALYs, used two methods, one indicating that QALYs should not be weighted and the other that greater weight could be given to QALYs gained by some groups. SUMMARY: Although we conducted only a feasibility study and a modelling exercise, neither present compelling evidence for moving the NICE threshold up or down. Some preliminary evidence would indicate it could be moved up for some types of QALY and down for others. While many members of the public appear to be open to the possibility of using somewhat different QALY weights for different groups of beneficiaries, we do not yet have any secure evidence base for introducing such a system. |
format | Text |
id | pubmed-3023672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30236722011-01-20 The social value of a QALY: raising the bar or barring the raise? Donaldson, Cam Baker, Rachel Mason, Helen Jones-Lee, Michael Lancsar, Emily Wildman, John Bateman, Ian Loomes, Graham Robinson, Angela Sugden, Robert Prades, Jose Luis Pinto Ryan, Mandy Shackley, Phil Smith, Richard BMC Health Serv Res Debate BACKGROUND: Since the inception of the National Institute for Health and Clinical Excellence (NICE) in England, there have been questions about the empirical basis for the cost-per-QALY threshold used by NICE and whether QALYs gained by different beneficiaries of health care should be weighted equally. The Social Value of a QALY (SVQ) project, reported in this paper, was commissioned to address these two questions. The results of SVQ were released during a time of considerable debate about the NICE threshold, and authors with differing perspectives have drawn on the SVQ results to support their cases. As these discussions continue, and given the selective use of results by those involved, it is important, therefore, not only to present a summary overview of SVQ, but also for those who conducted the research to contribute to the debate as to its implications for NICE. DISCUSSION: The issue of the threshold was addressed in two ways: first, by combining, via a set of models, the current UK Value of a Prevented Fatality (used in transport policy) with data on fatality age, life expectancy and age-related quality of life; and, second, via a survey designed to test the feasibility of combining respondents' answers to willingness to pay and health state utility questions to arrive at values of a QALY. Modelling resulted in values of £10,000-£70,000 per QALY. Via survey research, most methods of aggregating the data resulted in values of a QALY of £18,000-£40,000, although others resulted in implausibly high values. An additional survey, addressing the issue of weighting QALYs, used two methods, one indicating that QALYs should not be weighted and the other that greater weight could be given to QALYs gained by some groups. SUMMARY: Although we conducted only a feasibility study and a modelling exercise, neither present compelling evidence for moving the NICE threshold up or down. Some preliminary evidence would indicate it could be moved up for some types of QALY and down for others. While many members of the public appear to be open to the possibility of using somewhat different QALY weights for different groups of beneficiaries, we do not yet have any secure evidence base for introducing such a system. BioMed Central 2011-01-11 /pmc/articles/PMC3023672/ /pubmed/21223540 http://dx.doi.org/10.1186/1472-6963-11-8 Text en Copyright ©2011 Donaldson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Debate Donaldson, Cam Baker, Rachel Mason, Helen Jones-Lee, Michael Lancsar, Emily Wildman, John Bateman, Ian Loomes, Graham Robinson, Angela Sugden, Robert Prades, Jose Luis Pinto Ryan, Mandy Shackley, Phil Smith, Richard The social value of a QALY: raising the bar or barring the raise? |
title | The social value of a QALY: raising the bar or barring the raise? |
title_full | The social value of a QALY: raising the bar or barring the raise? |
title_fullStr | The social value of a QALY: raising the bar or barring the raise? |
title_full_unstemmed | The social value of a QALY: raising the bar or barring the raise? |
title_short | The social value of a QALY: raising the bar or barring the raise? |
title_sort | social value of a qaly: raising the bar or barring the raise? |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023672/ https://www.ncbi.nlm.nih.gov/pubmed/21223540 http://dx.doi.org/10.1186/1472-6963-11-8 |
work_keys_str_mv | AT donaldsoncam thesocialvalueofaqalyraisingthebarorbarringtheraise AT bakerrachel thesocialvalueofaqalyraisingthebarorbarringtheraise AT masonhelen thesocialvalueofaqalyraisingthebarorbarringtheraise AT jonesleemichael thesocialvalueofaqalyraisingthebarorbarringtheraise AT lancsaremily thesocialvalueofaqalyraisingthebarorbarringtheraise AT wildmanjohn thesocialvalueofaqalyraisingthebarorbarringtheraise AT batemanian thesocialvalueofaqalyraisingthebarorbarringtheraise AT loomesgraham thesocialvalueofaqalyraisingthebarorbarringtheraise AT robinsonangela thesocialvalueofaqalyraisingthebarorbarringtheraise AT sugdenrobert thesocialvalueofaqalyraisingthebarorbarringtheraise AT pradesjoseluispinto thesocialvalueofaqalyraisingthebarorbarringtheraise AT ryanmandy thesocialvalueofaqalyraisingthebarorbarringtheraise AT shackleyphil thesocialvalueofaqalyraisingthebarorbarringtheraise AT smithrichard thesocialvalueofaqalyraisingthebarorbarringtheraise AT donaldsoncam socialvalueofaqalyraisingthebarorbarringtheraise AT bakerrachel socialvalueofaqalyraisingthebarorbarringtheraise AT masonhelen socialvalueofaqalyraisingthebarorbarringtheraise AT jonesleemichael socialvalueofaqalyraisingthebarorbarringtheraise AT lancsaremily socialvalueofaqalyraisingthebarorbarringtheraise AT wildmanjohn socialvalueofaqalyraisingthebarorbarringtheraise AT batemanian socialvalueofaqalyraisingthebarorbarringtheraise AT loomesgraham socialvalueofaqalyraisingthebarorbarringtheraise AT robinsonangela socialvalueofaqalyraisingthebarorbarringtheraise AT sugdenrobert socialvalueofaqalyraisingthebarorbarringtheraise AT pradesjoseluispinto socialvalueofaqalyraisingthebarorbarringtheraise AT ryanmandy socialvalueofaqalyraisingthebarorbarringtheraise AT shackleyphil socialvalueofaqalyraisingthebarorbarringtheraise AT smithrichard socialvalueofaqalyraisingthebarorbarringtheraise |